Ray Dalio Eargo, Inc. Transaction History

Bridgewater Associates, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.6 - $10.21 $58,718 - $130,330	-12,765 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$6.59 - $38.71 $181,429 - $1.07 Million	-27,531 Reduced 68.32%	12,765 $86,000
Q2 2021 Aug 13, 2021	BUY	$32.1 - $57.78 $1.29 Million - $2.33 Million	40,296 New	40,296 $1.61 Million

33.4K

Ticker EAR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 39,411,000
Market Cap $2.78B
Description
Eargo, Inc., a medical device company, engages in enhancing the quality of life of people with hearing loss in the United States. The company markets and sells hearing aids. It sells its products direct-to-consumer and through omni-channel. The company was formerly known as Aria Innovations, Inc. and changed its name to Eargo, Inc. in November 2...

Get notified when there are updates to the investment portfolio of Bridgewater Associates, LP, based on Form 13F filings with the SEC.

Stay updated on Bridgewater Associates, LP and Ray Dalio with notifications on news.